Tandem ratio response Raman probe as well as preparation method and application thereof

By developing a self-ratio-type SERS probe with two-rate response in tandem, using gold nanobasins and targeting groups, the invasiveness of brain pH detection technology and the difficulty of crossing the blood-brain barrier is solved, and efficient in the neuroinflammatory environment is achieved , accurate pH fluctuation monitoring, and a deep understanding of brain function changes and disease progression.

CN119086521AActive Publication Date: 2024-12-06GUANGDONG HONG KONG MACAO GREATER BAY AREA PRECISION MEDICINE RESEARCH INSTITUTE (GUANGZHOU) +1

Patent Information

Application Number
CN202411134315.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-19
Publication Date
2024-12-06
Estimated Expiration
2044-08-19

AI Technical Summary

Technical Problem

The existing brain pH detection technology has problems such as strong invasiveness, slow operation speed, complex equipment procedures and difficulty in crossing the blood-brain barrier, resulting in inaccurate monitoring of pH fluctuations in neuroinflammatory environments.

Method used

A self-ratio-type surface-enhanced Raman scattering (SERS) probe with two-ratio-response in tandem is developed, consisting of gold nano substrates, dye molecules and polymers, with H2O2 and pH bi-ratio-responsiveness through targeting groups Cross the blood-brain barrier to achieve high sensitivity and specific pH fluctuation monitoring.

Benefits of technology

It realizes efficient and accurate pH fluctuation monitoring in a neuroinflammatory environment, can deeply understand the mechanisms of brain function changes and disease progression, and has the characteristics of high signal-to-noise ratio and low impact in non-lesion areas.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119086521A_ABST
    Figure CN119086521A_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field of molecular imaging, and particularly relates to a tandem ratio response Raman probe as well as a preparation method and application thereof. The Raman probe disclosed by the invention is a substance consisting of a gold nano substrate, dye molecules and a polymer, the gold nano substrate is good in chemical stability, rich in surface plasmon and capable of enhancing Raman signals; raman reporter molecules are connected to the surface of the substance, serial response of ROS and pH can be achieved, meanwhile, a raman peak which is basically unchanged serves as an internal reference, response peaks of the two markers and an internal reference raman spectrum peak are not overlapped, and accurate quantification of ROS and pH can be achieved. The reporter molecule has pH stability when the ROS does not respond, and can realize pH fluctuation monitoring after the ROS is started. According to the present invention, the neuroinflammation site in the brain microenvironment can be imaged, the pH fluctuation in the brain disease environment can be specifically imaged, the pH monitoring of the lesion site can be easily achieved, and the important significance can be provided for the deep understanding of the brain function change and the disease progress mechanism.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of molecular imaging, and in particular relates to a Raman probe and a preparation method and application thereof. Background Art

[0002] The pH value of the brain microenvironment is crucial in regulating cell signal transduction, cell death, memory formation, and maintaining the functional homeostasis of neuronal electrical activity and neural circuits. Normally, the extracellular pH of the brain is regulated by transporters such as Na + / HCO3 - Cotransporters and Cl - / HCO3 - Exchangers) and pH-sensitive membrane proteins expressed by neurons and glial cells, such as acid-sensing ion channels ASICs, are maintained within the range of 7.2 to 7.4. Due to the sensitivity of membrane proteins such as ion channels, transporters, and ATPase pumps to pH, even small fluctuations of 0.1 to 0.2 pH units may have significant effects on neural status, glial function, and neurotransmitter regulation. In general, increases in microenvironmental pH enhance neuronal excitability, while acidification reduces excitability. Notably, the relationship between pH and neuronal excitability is not simple. Specifically, some neurons (such as chemically sensitive neurons) show increased excitability under acidic conditions, while other neurons (such as hippocampal neurons) may show the opposite response. In addition, disturbances in the extracellular acid-base balance of the brain, whether acute or chronic, may significantly contribute to the initiation and progression of neurological diseases such as schizophrenia, brain tumors, epilepsy, and aging. Given the correlation between brain pH and neurological function and brain diseases, dynamic measurement of brain pH fluctuations in vivo is essential for a deep understanding of the mechanisms of brain function changes and disease progression.

[0003] Currently, a variety of brain pH detection techniques have been developed, including electrochemical measurement, magnetic resonance imaging (MRI), magnetic resonance spectroscopy (MRS), and fluorescence imaging. Among them, electrochemical detection using microelectrodes is the most direct method to detect brain pH, with good sensitivity and simple procedures. However, the direct interaction between the rigid electrode interface and brain tissue may affect the activity of neurons or glial cells, thereby affecting the accuracy of pH measurement and bringing significant invasive risks. As a non-invasive alternative, various magnetic resonance techniques, including 31 P MRS, 1 H MRS and 1H MRI can provide quantitative information for pH determination. However, challenges faced by these techniques include slow acquisition speed, the need for dedicated hardware and coil equipment, and complex operating procedures. Fluorescence imaging has demonstrated significant advantages in pH imaging, including high sensitivity, simplicity, and high spatiotemporal resolution. However, the selective physiological barrier of the central nervous system - the blood-brain barrier (BBB) ​​- prevents many exogenous substances, including drugs and probes, from effectively entering the brain parenchyma. Therefore, although many fluorescent probes for pH detection have been developed, the challenge of crossing the BBB and achieving pH-specific optical imaging at the lesion remains.

[0004] Raman spectroscopy originates from the inelastic scattering of incident light when it interacts with target molecules, which directly or indirectly provides specific spatial resolution and chemical insights into molecular structure and conformation. As an ideal alternative for molecular imaging or sensing, Raman spectroscopy surpasses the limitations of fluorescence, such as susceptibility to photobleaching and autofluorescence. In addition, the inherent low sensitivity of Raman scattering can be improved by surface-enhanced Raman scattering (SERS), even reaching the level of single-molecule detection after adsorption onto wrinkled metal surfaces. Importantly, SERS can be precisely tailored through surface modification to improve biocompatibility, cross physiological barriers, selectively target specific cells or even organelles. However, SERS probes often encounter problems such as nonspecific aggregation, uneven distribution, and susceptibility to working conditions when used in vivo, resulting in ambiguous or even inaccurate detection signals. Ratiometric strategies provide a promising way to improve detection accuracy by adopting signal self-calibration methods.

[0005] Although the pathological mechanisms behind neurological diseases are diverse, including protein aggregation, systemic infection, aging, and genetic mutations, their common feature is chronic neuroinflammation. Autoimmune neurological diseases (such as multiple sclerosis) are characterized by the infiltration of peripheral inflammatory cells, while primary neurodegenerative diseases (such as Alzheimer's disease and epilepsy) often show significant microglia and astrocyte activation. In the context of neuroinflammation, increased enzyme activity, especially that of NADPH oxidase, leads to aggravated mitochondrial dysfunction and increased production of reactive oxygen species (ROS). This leads to oxidative damage and thus amplifies the inflammatory response. At the same time, neuroinflammation stimulates the synthesis and release of proinflammatory mediators including cytokines, chemokines, complement components, and free radicals, ultimately leading to impaired brain function and structural changes. Studies have shown that hydrogen peroxide (H2O2) is upregulated in the context of neuroinflammation.

[0006] Based on this, a ratiometric SERS probe that can cross the blood-brain barrier and be turned on by H2O2 is constructed for specific imaging of pH fluctuations in the brain disease environment, which is an important technology for in-depth understanding of changes in brain function and the mechanism of disease progression. Summary of the invention

[0007] The purpose of the present invention is to provide a self-ratio SERS probe with tandem dual ratio response, high ratio signal, good stability, high brain entry efficiency, high sensitivity and good biosafety, as well as a preparation method and application thereof, to solve the technical problems of existing imaging brain pH, especially specific imaging of pH fluctuations in brain disease environments, such as high invasiveness, slow operation speed, complex equipment procedures, and blood-brain barrier penetration barriers, so as to facilitate accurate monitoring of pH fluctuations in brain disease environments.

[0008] The tandem ratio-responsive Raman probe provided by the present invention is a substance composed of a gold nano-substrate, a dye molecule and a polymer, and its structure is shown in the following formula V:

[0009]

[0010] Wherein, A is the gold nanosubstrate;

[0011] X 1 The structure is as shown in Formula I a As shown:

[0012]

[0013] Among them, S is connected to the gold on the surface of A through a gold-sulfur bond, and R 1 and R 2 R is independently hydrogen, halogen, C1-C4 alkyl, sulfonic acid or nitro; 1 and R 2 Same or different.

[0014] X 2 For L 1 -L 2 , L 1 is a group connected to the gold on the surface of A through a gold-sulfur bond, L 2 It is a hydrophilic polymer group, and the middle - indicates that the two are connected, the same below;

[0015] X 3 For L 1 -L 3 -L 4 , L 1 is a group connected to the gold on the surface of A through a gold-sulfur bond, L 3 is a hydrophilic polymer group, L 4 The targeting group.

[0016] A is used as a substrate for Raman signal enhancement to provide electromagnetic field hotspots to enhance the Raman reporter molecule X 1 Raman signal, improving the sensitivity of detection; X 1It is a reaction molecule with dual ratio responsiveness to H2O2 and pH, used to provide a quantitative basis for the target marker; X 2 Used to increase the biocompatibility of the probe; X 3 Endowing the probe with the ability to efficiently cross the blood-brain barrier.

[0017] The A is a conventional gold nanosubstrate in the art, and the shape of A is preferably a multi-branched star, polygonal, rod-shaped or spherical, further preferably a multi-branched star or polygonal, and more preferably a multi-branched star.

[0018] The particle size of A is 5 nm to 200 nm, preferably 10 nm to 100 nm, and more preferably 50±20 nm.

[0019] The A is prepared by the following method: in a solvent, chloroauric acid, gold seeds, silver nitrate and ascorbic acid are reacted to form a gold-sulfur bond to obtain A.

[0020] In the substance shown in formula V:

[0021] X 1 The molar ratio of A is 1×10 4 :1~5×10 4 :1, preferably 1×10 4 :1~3×10 4 :1, more preferably 2×10 4 :1.

[0022] X 2 The molar ratio of A is 5×10 4 :1~50×10 4 :1, preferably 10×10 4 :1~40×10 4 :1, more preferably 15×10 4 :1.

[0023] X 3 The molar ratio of A is 1×10 6 :1~3×10 6 :1, preferably 1.5×10 6 :1~3.5×10 6 :1, more preferably 2×10 6 :1.

[0024] Further:

[0025] The halogen is Cl, Br or I;

[0026] The C1-C4 alkyl group is methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl or tert-butyl, preferably methyl.

[0027] The X 2 In the structure:

[0028] The L 1 The structure is:

[0029]

[0030] The L 2 It is a polyethylene glycol group, a polyethylene glycol derivative group, a polylysine group or a polyethylene imine group; preferably a polyethylene glycol derivative group.

[0031] The L 2 The molecular weight is 1,000 to 10,000, preferably 4,000 to 6,000, and more preferably 5,000.

[0032] The L 2 It is a polyethylene glycol group, and its structure is:

[0033]

[0034] The X 2 The structure is L 1 -L 2 , when L 2 When it is a polyethylene glycol group, the structure of X2 is:

[0035]

[0036] The L 3 It is a polyethylene glycol group modified with a maleimide group, a polyethylene glycol derivative group modified with a maleimide group, a polylysine group modified with a maleimide group, or a polyethyleneimine group modified with a maleimide group, preferably a polyethylene glycol derivative group modified with a maleimide group.

[0037] The L 3 The molecular weight is 1,000 to 10,000, preferably 4,000 to 6,000, and more preferably 5,000.

[0038] The L 3 It is a polyethylene glycol group modified with a maleimide group, and its structure is:

[0039]

[0040] The L 4 It is a targeting group that crosses the blood-brain barrier, preferably a targeting neuroinflammatory-related receptor group, and more preferably a receptor for advanced glycation end products (RAGE) targeting peptide, The anti-VCAM-1 antibody group or the anti-IL-1β antibody group is particularly preferably a RAGE targeting peptide.

[0041] The L 4 It is a RAGE targeting peptide with the amino acid sequence: CELKVLMEKEL.

[0042] X 3 For L 1 -L 3 -L 4 , when L 3 is a polyethylene glycol group, L 4 When targeting RAGE peptide, X 3 The structural formula is:

[0043]

[0044] Further:

[0045] The hydrated particle size of the substance represented by Formula V may be 110±30 nm.

[0046] The surface charge of the substance represented by Formula V may be 9±5 mV.

[0047] The substance represented by Formula V may have a Raman effect.

[0048] The Raman spectrum formed by the substance represented by Formula V has one or more of the following characteristic peaks: 303 cm -1 、482cm -1 、520cm -1 、552cm -1 、590cm -1 、928cm -1 、790cm -1 、1169cm -1 and 1430cm -1 The characteristic peak at .

[0049] The characteristic peak of the Raman spectrum formed by the substance represented by Formula V is 303 cm -1 、482cm -1 、520cm -1 、552cm -1 、590cm -1 、928cm -1 、790cm -1 、1169cm -1 and 1430cm -1 The characteristic peak at .

[0050] The characteristic peak of the Raman spectrum formed by the substance represented by Formula V is 482 cm -1 、590cm -1 and 928cm -1 The characteristic peak at .

[0051] The substance represented by formula V can be used as a probe.

[0052] The substance represented by formula V can be used to detect active oxygen, and the active oxygen can be superoxide anion, hydrogen peroxide, singlet oxygen, hydroxyl radical, lipid peroxide radical, ozone, hypochlorite or hypobromite, especially hydrogen peroxide.

[0053] The concentration of the active oxygen may be 5 μmol / L to 100 μmol / L.

[0054] The substance represented by formula V can be used to detect pH in an active oxygen environment, and the pH range can be 2.0 to 10.0.

[0055] The substance represented by formula V can be used to detect organs, tissues or cells, such as brain tissues or neuronal cells.

[0056] The substance represented by formula V can be used to detect organs, tissues or cells containing active oxygen and their pH. The organs, tissues or cells containing active oxygen can be neuronal cells or brain tissue (such as epileptogenic focus).

[0057] The present invention also provides a method for preparing a substance represented by formula V, comprising the following steps: in a solvent, placing a gold nano-substrate A, I a The substance X shown 1 、Polymer X 2 and polymer X 3 Reaction to obtain substance V.

[0058] The solvent is an alcohol solvent and / or a water solvent, preferably an alcohol solvent and water.

[0059] The alcohol solvent is preferably methanol and / or ethanol, more preferably methanol.

[0060] The aqueous solvent is deionized water, distilled water or purified water, more preferably deionized water.

[0061] When the solvent is a combination of an alcohol solvent and an aqueous solvent, the volume ratio of the alcohol solvent to the aqueous solvent is 1:10 to 1:500, preferably 1:50 to 1:150, and more preferably 1:80 to 1:100.

[0062] The substance I a The molar ratio of A is 1×10 4 :1~5×10 4 :1, preferably 1×10 4 :1~3×10 4 :1, more preferably 2×10 4 :1.

[0063] The polymer X 2The molar ratio of A is 1×10 3 :1~1×10 5 :1, preferably 1×10 4 :1~3×10 4 :1, more preferably 2×10 4 :1.

[0064] The polymer X 3 The molar ratio of A is 1×10 6 :1~5×10 6 :1, preferably 1×10 6 :1~3×10 6 :1, more preferably 2×10 6 :1.

[0065] The polymer X 2 With polymer X 3 The molar ratio is 1:50 to 1:1000, preferably 1:50 to 1:200, and more preferably 1:100.

[0066] The molar volume ratio of A to the solvent is 1:50 to 1:500, preferably 1:100 to 1:300, and more preferably 1:202.17.

[0067] The substance I a The molar volume ratio of the polyol to the solvent is (50-150):1, preferably 90:1-120:1, and more preferably 98.93:1.

[0068] The polymer X 3 The molar volume ratio to the solvent is 5000:1 to 15000:1, preferably 8000:1 to 10000:1, and more preferably 9892.66:1.

[0069] The A participates in the reaction in the form of a solution of A, and the concentration of A is 1-10 nmol / L, preferably 1 nmol / L.

[0070] The present invention provides a substance that uses gold nanoparticles as an enhanced substrate, has good chemical stability, rich surface plasmons, and can greatly enhance Raman signals. A Raman reporter molecule X is connected to the surface of the substance 1, the tandem response of ROS and pH can be achieved, and there is a basically unchanged Raman peak as a reference, and the ROS response peak, pH response peak and internal reference Raman peak do not overlap, which can achieve accurate quantification of ROS and pH. And the reporter molecule has pH stability when ROS does not respond, so it can realize pH fluctuation monitoring after ROS is turned on. When the substance interacts with ROS, the ROS response group structure of the reporter molecule changes, thereby causing the change of the corresponding Raman spectrum, and the ratio of the Raman peak of the non-responsive group to the characteristic peak formed by it increases (I does not respond / I responds to ROS). On this basis, the substance turns on pH responsiveness, and the pH response group of the reporter molecule changes its structure at different pH, thereby causing the change of the corresponding Raman spectrum, and the ratio of the Raman peak of the non-responsive group to the characteristic peak formed by it increases (I does not respond / I responds to pH).

[0071] The present invention provides a substance with tandem dual responsiveness and self-ratio calibration, high ratio signal, good stability, high sensitivity and other advantages. It can image the neuroinflammation site in the brain microenvironment, and then specifically image the pH fluctuation in the brain disease environment, which is beneficial to the pH monitoring of the lesion site, and has great significance for in-depth understanding of the mechanism of brain function changes and disease progression. In addition, the targeting group connected to the substance can specifically identify the receptor for advanced glycation end products (RAGE) highly expressed on cerebral vascular endothelial cells in the neuroinflammation site, guide the imaging probe to cross the blood-brain barrier through transcytosis, and achieve targeted enrichment and signal activation in the neuroinflammation area. In the inflammatory area, the probe responds to ROS, the Raman signal undergoes a ratiometric change, and the pH monitoring capability is turned on at the same time, realizing the specific monitoring of pH fluctuations in the lesion site to study the correlation between brain function and brain disease.

[0072] Compared with the various brain pH detection technologies that have been developed, a substance of the present invention has the characteristics of "efficient entry into the brain across the blood-brain barrier", "low impact on non-lesion areas", "specific response in lesion areas", "ROS and pH tandem dual responsiveness", and "self-ratio calibration". It can effectively improve the signal-to-noise ratio of the lesion site, and can depict pH fluctuations in various brain disease environments to deeply study its mechanism and develop new treatment strategies. BRIEF DESCRIPTION OF THE DRAWINGS

[0073] Figure 1 The ratiometric SERS probe is used to image H2O2 and pH fluctuations in neuronal cells. A is a schematic diagram of the isolation, culture and Raman imaging of primary mouse neurons, B is a bright field image of patch clamp recording of neuronal electrophysiology, C is a representative electrophysiological result of neurons under different stimuli, and D is a confocal Raman imaging of endogenous H2O2 and pH levels in primary mouse neurons under different stimuli.

[0074] Figure 2The HCB probe is used to image pH fluctuations in epilepsy model mice. A is a schematic diagram of the process of in situ brain SERS imaging of epilepsy mouse models using the HCB probe. B is the simultaneous recording of neural electrical activity and SERS ratio in mice with different epileptic seizure levels to monitor pH fluctuations in the mouse brain. The top is a representative EEG result. The middle is a representative EEG energy spectrum. The bottom is the change of pH in the mouse brain over time recorded by the HCB probe.

[0075] Figure 3 The SERS ratio images of the brain of epileptic mice injected with SERS probe V before, during and after different drug treatments. The left side shows representative EEG results. The middle is a pseudo-color image. 928 / I 482 Ratio image, depicting H2O2 concentration. Pseudo-color image on the right 928 / I 590 Ratio graphs show pH values. DETAILED DESCRIPTION

[0076] The present invention is further described below by way of examples, but the present invention is not limited to the scope of the examples. The experimental methods in the following examples without specifying specific conditions are carried out according to conventional methods and conditions, or selected according to the product specifications.

[0077] Example 1: Synthesis of substance Ia

[0078]

[0079] 40 mL of N,N-dimethylformamide (DMF, 0.5 mol) and 40 mL of dichloromethane solution were mixed evenly and placed in an ice-salt bath for 30 min. 37 mL of phosphorus oxychloride (0.4 mol) and 10 g of cyclohexanone (I-1, 0.1 mol) were mixed evenly and then gradually added dropwise to the above mixture. Reflux reaction for 3 h, and when the reaction solution returned to room temperature, it was poured into 200 g of crushed ice and cooled overnight. The yellow solid was collected by filtration to obtain the target product chlorodialdehyde (I-2).

[0080] 320 mg of indole substance (I-3, 2 mmol) and 950 μL of 2-iodoethanol (12.2 mmol) were dissolved in 15 mL of o-dichlorobenzene. The mixture was refluxed at 100°C for 48 h and allowed to stand to precipitate a crude product. The crude product was washed with 500 mL of acetone to obtain indoleethanol (I-4).

[0081] Further, 203 mg of chlorodialdehyde (I-2, 1.18 mmol) and 730 mg of indoleethanol (I-4, 2.26 mmol) were dissolved in 50 mL of a mixed solvent of n-butanol and toluene (C4H 10O:C7H8=7:3, V:V), reflux at 120℃ and stir overnight. After the system was spin-dried, the crude product was dissolved with 5mL of methanol, and the methanol solution was added dropwise to 150mL of ice ether with vigorous stirring, filtered and dried to obtain a crude product. The crude product was dissolved with 2mL of a mixed solution of dichloromethane and methanol in a volume ratio of 2:1 to obtain a solution to be purified. Then, the solution to be purified was separated and purified using silica gel column chromatography to obtain a dark green substance Cy7-Cl(I-5).

[0082] The specific operating conditions for separation and purification by silica gel column chromatography are as follows:

[0083] Silica gel column: inner diameter 40mm, length 300mm, packed with 200-300 mesh silica gel;

[0084] Elution conditions: After loading the solution to be purified, first use 100 mL of dichloromethane, then use 500 mL of a dichloromethane-methanol mixed solvent (CH2Cl2:CH4O=15:1, V:V), and finally use 300 mL of a dichloromethane-methanol mixed solvent (CH2Cl2:CH4O=5:1, V:V) for elution. The elution rate is controlled at 30 mL / min to 80 mL / min.

[0085] Then, triethylamine (7.34mmol, 20eq) and resorcinol (3.67mmol, 10eq) were dissolved in N,N-dimethylformamide (DMF). Stirred at room temperature for 30min. Then, substance I-5 (0.37mmol, 1.0eq) was added, and the reaction was stirred at 88°C for 6h. The system was spin-dried and dissolved with 2mL of a mixed solution of dichloromethane and methanol with a volume ratio of 2:1 to obtain a solution to be purified. Then, silica gel column chromatography was used to separate and purify the solution to be purified to obtain a blue substance Hem-H (I-6).

[0086] The specific operating conditions for separation and purification by silica gel column chromatography are as follows:

[0087] Silica gel column: inner diameter 40mm, length 300mm, packed with 200-300 mesh silica gel;

[0088] Elution conditions: After loading the solution to be purified, first use 200 mL of dichloromethane, then use 1500 mL of a dichloromethane-methanol mixed solvent (CH2Cl2:CH4O=12:1, V:V), and finally use 500 mL of a dichloromethane-methanol mixed solvent (CH2Cl2:CH4O=4:1, V:V) for elution. The elution rate is controlled at 30 mL / min to 80 mL / min.

[0089] Then, substance I-6 (207 mg, 0.5 mmol), 4-bromomethylphenylboronic acid pinacol ester (193 mg, 0.65 mmol), and K2CO3 (83 mg, 0.6 mmol) were dissolved in anhydrous dimethylformamide (DMF, 30 mL) and reacted at 50 ° C for 6 h under nitrogen protection. The system was spin-dried and dissolved in 2 mL of a mixed solution of dichloromethane and methanol with a volume ratio of 2:1 to obtain a solution to be purified. Then, silica gel column chromatography was used to separate and purify the solution to be purified to obtain a dark blue substance Hem-HB (I-7).

[0090] The specific operating conditions for separation and purification by silica gel column chromatography are as follows:

[0091] Silica gel column: inner diameter 40mm, length 300mm, packed with 200-300 mesh silica gel;

[0092] Elution conditions: After loading the solution to be purified, first use 100 mL of dichloromethane, then use 500 mL of a dichloromethane-methanol mixed solvent (CH2Cl2:CH4O=15:1, V:V), and finally use 300 mL of a dichloromethane-methanol mixed solvent (CH2Cl2:CH4O=5:1, V:V) for elution. The elution rate is controlled at 30 mL / min to 80 mL / min.

[0093] Finally, substance I-7 (0.18mmol, 1.0eq) was mixed with dimethylaminopyridine (DMAP, 0.55mmol, 3.0eq), thioctic acid (0.18mmol, 1.0eq) and dicyclohexylcarbodiimide (DCC, 0.55mmol, 3.0eq) in 5.0mL dichloromethane. The reaction was stirred at room temperature in the dark for 18h. The system was spin-dried and dissolved with a 2mL mixed solution of dichloromethane and methanol in a volume ratio of 2:1 to obtain a solution to be purified. Then, silica gel column chromatography was used to separate and purify the solution to be purified to obtain a dark blue substance Hem-HBS (Ia).

[0094] The specific operating conditions for separation and purification by silica gel column chromatography are as follows:

[0095] Silica gel column: inner diameter 40mm, length 300mm, packed with 200-300 mesh silica gel;

[0096] Elution conditions: After loading the solution to be purified, first use 100 mL of dichloromethane, then use 900 mL of a dichloromethane-methanol mixed solvent (CH2Cl2:CH4O=20:1, V:V), and finally use 500 mL of a dichloromethane-methanol mixed solvent (CH2Cl2:CH4O=5:1, V:V) for elution. The elution rate is controlled at 30 mL / min to 80 mL / min.

[0097] 1H NMR (400MHz, CDCl3) δ: 8.63 (d, 1H, J = 14.78Hz), 7.87 (d, 2H, J = 8.00Hz), 7.49-7.33 (m, 8H), 7.20 (s, 1H), 6. 95(dd,1H,J=8.62,2.38Hz),6.87(d,1H,J=2.35Hz),6.78(d,1H,J=14.80Hz),5.25(s,2H),5.03(t,2H,J=5. 10Hz),4.72(t,2H,J=5.23Hz),3.46-3.41(m,1H),3.13-3.08(m,2H),2.89(t,2H,J=6.20Hz),2.74(t,2H,J= 6.27Hz),2.42-2.36(m,1H),2.09-2.06(m,2H),1.97-1.91(m,2H),1.77(s,6H),1.58(s,6H),1.34(s,12H).

[0098] ESI-MS calculation for C 48 H 57 BNO6S2[M+H] + :818.3715, found 818.3721.

[0099] Example 2: Synthesis of polymer III-a

[0100]

[0101] 5 g of amino-polyethylene glycol 5000-maleimide (1.0 mmol), 309 g of lipoic acid (1.5 mmol), 570 mg of HATU (1.5 mmol) and 258 mg of N,N-diisopropylethylamine (DIPEA, 2 mmol) were added to 5 mL of anhydrous DMF and stirred at room temperature for 24 h. Then, a dialysis bag with a molecular weight cutoff of 5000 was used for dialyzation purification with 5 L of deionized water, which was replaced 3 times; each dialysis was 5 h. After dialysis, the mixture was frozen in a refrigerator at ~80°C for 24 h, and then freeze-dried in a freeze dryer to obtain the polymer Lip-PEG-MAL (III-1).

[0102] Take 52 mg Lip-PEG-MAL (10 umol), dissolve it in 5 mL PBS (pH = 6.8) acetonitrile mixed solution (PBS / acetonitrile = 8:2, V / V), then add 13.34 mg Cys-Angiopep2 (10 umol), stir at room temperature for 24 hours, and then use a dialysis bag with a molecular weight cutoff of 5000 to dialyze and purify with 5L deionized water, change 3 times, each dialysis for 5 hours, freeze it in a -80°C refrigerator for 24 hours after dialysis, and then freeze-dry it in a freeze dryer to obtain the polymer Lip-PEG-RAGE (III-a).

[0103] Example 3: Synthesis of probe HCB

[0104] Using methanol as solvent, a methanol solution of substance Ia with a concentration of 1 mol / L was prepared for later use.

[0105] Using methanol as solvent, a methanol solution of polymer II-a with a concentration of 1 mol / L was prepared for later use.

[0106] Using methanol as solvent, a methanol solution of polymer III-a with a concentration of 1 mol / L was prepared for later use.

[0107] Use deionized water to prepare 100 mL of 1 mM chloroauric acid solution, slowly add 15 mL of 1% citric acid deionized water solution to the chloroauric acid solution, boil for 15 minutes to obtain a gold seed solution with a particle size of 5 to 20 nm and a concentration of 0.01 nmol / L.

[0108] 200 mL of 0.3 mM chloroauric acid solution was prepared with deionized water, and the pH of the chloroauric acid solution was adjusted to acidic (pH = 2) with pH = 1 hydrochloric acid. 4 mL of the above gold seed solution was added under stirring conditions of 650 rpm / r. Further, the stirring speed of the solution was increased to 1500 rpm / r, and 2 mL of 3.0 mmol / L silver nitrate deionized water solution and 1.2 mL of 100 mmol / L ascorbic acid deionized water solution were added at the same time. After stirring for 20 seconds, a gold nanostar solution with a particle size of 50 ± 20 nm was obtained.

[0109] The gold nanostar solution prepared above was prepared with deionized water to prepare a gold nanostar solution with a concentration of 5.0 nmol / L for later use.

[0110] Take 200 mL of the above-prepared gold nanostar solution with a concentration of 5.0 nmol / L, first add 20 μl of the methanol solution of substance Ia and react at room temperature for 5 min, then add 2 mL of the methanol solution of polymer II-a and react at room temperature for 5 min, and finally add 150 μl of the methanol solution of polymer III-a and react at room temperature for 5 h to obtain the final probe HCB solution.

[0111] The structure of the probe HCB is shown below:

[0112]

[0113] in,

[0114] The structure of I-a' is:

[0115]

[0116] The structure of II-a' is:

[0117]

[0118] The structure of III-a' is:

[0119]

[0120] Characterization of probe HCB:

[0121] Probe morphology: The morphology of the probe HCB was completed by transmission electron microscopy experiment. 10 μL of the probe deionized water solution prepared above was taken and dropped on a copper mesh. It was dried with an infrared lamp and observed under a transmission electron microscope. The probe HCB showed a uniform nanostar shape with many branches and a particle size of 50±20 nm.

[0122] Particle size of the probe: The particle size of the probe was measured by dynamic light scattering on a Malvern particle size analyzer. The probe prepared above was deionized and diluted to 0.1 nmol / L. 1 mL of the sample was placed in a Malvern sample cell and tested on the instrument. The hydrated particle size of the probe was measured to be approximately 110 ± 30 nm.

[0123] Raman spectrum of the probe: We used a handheld Raman spectrometer to measure the Raman spectrum of HCB. Take 0.5mL of a probe solution with a concentration of 1nmol / L, apply an external laser to directly irradiate the probe solution, and collect the Raman spectrum after excitation with 785nm excitation light. The collection time is 0.5s. The attribution of the characteristic peaks of the probe HCB is shown in Table 1 below.

[0124] Table 1 Attribution of characteristic peaks of probe HCB (Raman spectrum intensity unit: counts).

[0125]

[0126] Example 4: Test of the response performance of probe HCB to H2O2

[0127] The Raman spectrum of the probe HCB in response to H2O2 was measured using a handheld Raman spectrometer. Take 1mL of 1nmol / L probe HCB, add 10uL of H2O2 water solution of different concentrations, and the concentrations of H2O2 are 0, 10μmol / L, 20μmol / L, 30μmol / L, 40μmol / L, 50μmol / L, 60μmol / L, 70μmol / L, 80μmol / L, 90μmol / L, 100μmol / L. After the probe reacts with H2O2 for 1min, collect the Raman spectrum of the probe HCB after excitation with 785nm excitation light. The characteristic peaks and peak attribution in the spectrum are shown in Table 2 below.

[0128] Table 2: Raman spectrum attribution data of probe HCB in response to H2O2 (Raman spectrum intensity unit: counts).

[0129]

[0130] The variation of the Raman spectrum characteristic peak intensity of the probe HCB with the concentration of H2O2 was further investigated, and the results are shown in Table 3.

[0131] Table 3: Characteristic peak intensity data of probe HCB at different H2O2 concentrations (Raman spectrum intensity unit: counts).

[0132]

[0133] As shown in Table 3, the Raman peak (peak 482 cm -1 The peak intensity of the peak at 930 cm-1 was significantly reduced after the action of H2O2, while the Raman peak (peak 930 cm-1) belonging to the symmetrical stretching of the C─C─C of the cyclohexene cycloalkyl group was -1 The peak intensity remains relatively stable after the action of H2O2. When the H2O2 concentration is constant, the characteristic double peak intensity ratio (I Peak2 / I Peak1 ) Raman signal intensity ratio increased from 3.99 to 93.28, an increase of more than 20 times. Peak2 / I Peak1 The signal intensity ratio is plotted against the H2O2 concentration. Within a certain H2O2 concentration range, I Peak2 / I Peak1 The value is positively correlated with the H2O2 concentration.

[0134] Example 5: pH response performance test of probe HCB after responding to ROS

[0135] First, the Raman spectrum of the probe HCB in response to pH was measured using a handheld Raman spectrometer. 1 mL of 1 nmol / L probe HCB was added to citric acid-sodium bicarbonate buffer solutions with different pH values, and the Raman spectrum of the probe HCB was collected after excitation with 785 nm excitation light. The characteristic peaks and peak attributions in the spectrum are shown in Table 4 below.

[0136] Table 4: Raman spectrum attribution data of probe HCB in response to pH (Raman spectrum intensity unit: counts).

[0137]

[0138] The variation of the characteristic peak intensity of the Raman spectrum of the probe HCB with the pH concentration was further investigated, and the results are shown in Table 5.

[0139] Table 5: Characteristic peak intensity data of probe HCB at different pH values ​​(Raman spectrum intensity unit: counts).

[0140]

[0141] As shown in Table 5, the Raman peak (peak 482 cm -1 The Raman peak of the CC bending vibration of the benzene ring (peak 590 cm -1 The Raman peak of the stretching of cyclohexene cycloalkyl C─C─C (peak 930 cm -1 The peak intensity at different pH values ​​remained relatively stable. When there was no H2O2 and the probe HCB concentration remained unchanged, the characteristic double peak intensity ratio (I Peak3 / I Peak1 and I Peak3 / I Peak2 ) Raman signal intensity ratio remains basically unchanged. Peak3 / I Peak1 and I Peak3 / I Peak2 The signal intensity ratio is plotted against pH value. Within a certain pH range, I Peak3 / I Peak1 and I Peak3 / I Peak2 The value is not affected by pH.

[0142] Secondly, the Raman spectrum of the pH response of the probe HCB to ROS was measured using a handheld Raman spectrometer. 1 mL of 1 nmol / L probe HCB was added with 100 μmol / L H2O2 for 1 min, and then added to citric acid-sodium bicarbonate buffer solutions with different pH values. The Raman spectrum of the probe HCB was collected after excitation with 785 nm excitation light. The characteristic peaks and peak attributions in the spectrum are shown in Table 6 below.

[0143] Table 6: Raman spectrum attribution data of probe HCB in response to pH (Raman spectrum intensity unit: counts).

[0144]

[0145] The change of the characteristic peak intensity of the Raman spectrum of the probe HCB after the action of H2O2 with the pH concentration was further investigated. The results are shown in Table 7.

[0146] Table 7: Characteristic peak intensity data of probe HCB at different pH values ​​under the action of H2O2 (Raman spectrum intensity unit: counts).

[0147]

[0148] As shown in Table 7, the Raman peak (peak 590 cm -1 The Raman peak (peak 930 cm) attributable to the stretching of the cycloalkyl C─C─C of cyclohexene increases significantly with increasing pH. -1 The peak intensity at different pH values ​​remained relatively stable. When the probe HCB concentration remained unchanged after the action of H2O2, the characteristic double peak intensity ratio (I Peak2 / I Peak1 ) Raman signal intensity ratio decreased from 13.19 to 0.87, an increase of more than 15 times. Peak2 / I Peak1 The signal intensity ratio is plotted against pH value. Within a certain pH range, I Peak2 / I Peak1 The value is positively correlated with pH.

[0149] Example 6: Probe HCB imaging of neurons in different states

[0150] 24 hours in advance, a glass disc with a diameter of 14 mm was taken with sterile forceps and placed in a culture plate, and 0.05% poly-lysine was added for plating. After 2 hours of coating at room temperature, it was sucked off, rinsed with phosphate buffer saline (PBS) three times, and dried for use. The brain tissue of C57BL / 6J suckling mice within 48 hours of birth was extracted and placed in a culture dish containing pre-cooled PBS. The meninges and blood vessels were removed, and the bilateral hippocampal tissue was isolated. The hippocampal tissue was transferred to papain solution (2 mg / mL, diluted in high-glucose DMEM) with sterile forceps, and an appropriate amount of DNaseI was added to prevent the release of DNA after digestion and entanglement with proteins to affect further digestion. It was placed in a 37°C incubator, and the cross was taken out and shaken lightly every 5 minutes. After 20 minutes, the digestion was terminated with a full-effect culture medium containing 10% FBS. Gently blow with a pipette, collect the cell suspension with a 70μm cell screen, centrifuge at 1000rpm for 5 minutes, and carefully aspirate the supernatant with a pipette to prevent the bottom cells from being blown away or aspirated during the process. Then, the cells were gently pipetted to resuspend in 10% FBS complete medium. After counting, the cells were appropriately diluted to 4x10 4 / cm 2 The cells were inoculated at a density of 100 μg / cm2 on a poly-lysine coated glass slide. The cells were cultured in a 37°C, 5% CO2 incubator. After 4 hours, the neurons were observed for adhesion to the wall and 10% NB27 culture medium was added to the culture plate according to a certain ratio. The next day, the medium was replaced by half of the NB culture medium. Thereafter, the cell growth was observed and the medium was replaced by half every three days.

[0151] After the CTZ powder returns to room temperature, quickly weigh 0.39 mg, add 100 μL DMSO to dissolve, and set it to a mother solution with a concentration of 10 mM. Using the gradient dilution method, add NB27 culture medium dropwise and shake to fully dissolve, and finally obtain a working solution with a concentration of 100 μM, which is filtered through a 0.45 μm needle filter membrane before use. Replace the culture medium in the original well plate with 40 μL CTZ working solution, and mix it by sticking it on the table in a cross manner to make the final concentration of CTZ 5 μM. Primary hippocampal neuronal cells were cultured for 48 hours at 37°C in an environment containing 5% CO2, and then taken out. The spontaneous discharge of neurons was recorded by patch clamp to confirm that chronic treatment with CTZ successfully induced epileptic discharges, such as Figure 1 shown.

[0152] The cell chamber matched with the inverted microscope stage is connected to the artificial cerebrospinal fluid perfusion system. The chamber is filled with liquid using a mechanical peristaltic pump to make the inflow and outflow of the perfusion system equal. The cell slide is taken out from the cell culture box and placed in the chamber. The field of view is adjusted under the inverted microscope, and pyramidal neurons with full morphology, good refractive index, and complete axons are selected for recording. The recording electrode uses a Sutter blank electrode (outer diameter OD: 1.5mm, inner diameter ID: 0.86mm), which is made by a P-2000 glass electrode puller. After filling the electrode with liquid, remove the bubbles. The resistance of the glass recording electrode is 3-5MΩ. Before the electrode is put into the liquid, a 1mL syringe is used to apply appropriate positive pressure to prevent the tip of the electrode from being blocked. The focus of the microscope and the electrode are adjusted to be close to the target cell. When the electrode is lightly pressed on the cell, a slight depression can be seen on the surface, and the resistance value increases (about 0.2-0.3MΩ). Slowly apply negative pressure to form a high-resistance peak connection (>1GΩ) between the electrode and the cell, break the cell membrane, and form a whole-cell electrophysiological recording state, such as Figure 1 As shown. The crosstalk resistance (Rs) was monitored during the recording, and cells with Rs greater than 60MΩ were excluded from the analysis. The cell membrane potential was clamped at -70mV in the current clamp mode, and 0 and 100pA stimulation was given. The number of action potentials (APs) induced under different current injections was used as an indicator of neuronal excitability. The experimental data were collected using the Axon Digidata 1550 data acquisition system and MultiClamp 700B amplifier with a sampling frequency of 10kHz. The collected data were analyzed using pCLAMP10.2 software. The number of neuronal action potentials under different stimuli is shown in Table 8.

[0153] From the data in Table 8, we can see that the excitability of neurons in the DMSO blank control group is the lowest. After adding CTZ stimulation, the number of action potentials of neurons under 100pA stimulation increases by about 4 times. After adding TPM treatment, the number of action potentials of neurons stimulated by CTZ decreased by 28.0%. After adding TPM and NAC combined treatment, the excitability of neurons was significantly reduced, and the number of action potentials decreased by 60.2%, which is close to that of cells in the blank control group. Figure 1 shown.

[0154] Add 100nmol / L HCB probe solution to neurons after different stimulations, and incubate the cells at 37°C and 5% CO2 for 2-8h. Discard the culture medium, rinse three times with 0.01M PBS, add 1mL HEPES buffer, and place under a 63× confocal Raman microscope for SERS mapping imaging. Grating: 300g / mm, spectral range: 0-3600cm -1 , excitation light: 785nm, laser power: 5mW, step length: 0.4μm.

[0155] Table 8: Neuronal firing activity, characteristic peak signals and characteristic peak intensity ratio data of two groups in different experimental groups (Raman spectrum intensity unit: counts).

[0156]

[0157] The characteristic peak data of the collected Raman images are shown in Table 8. It can be seen that the four groups of cells treated in different ways have a peak at 928 cm -1 When neurons were stimulated with CTZ, the intensity of 482 cm -1 and 590cm -1 The Raman peak intensity at I 928 / I 482 and I 928 / I 590 The ratio map signals were all enhanced, indicating that our probe HBF can identify the neuroinflammation level and pH fluctuation of epileptiform neurons. 928 / I 590 The ratio map signal was significantly lower than that of the CTZ group and recovered to the blank control group. In addition, after 24 hours of combined treatment of epileptiform neurons with TPM and NAC, I 928 / I 482 and I 928 / I 590 The ratio map signal was significantly lower than that of the CTZ group and had no significant difference from the blank control group, indicating that the probe we prepared had a high response sensitivity to H2O2 and pH changes.

[0158] Example 7: Application of probe HCB in real-time ratiometric SERS imaging in epileptic mice to non-invasively record pH fluctuations in the brain

[0159] Establishment of mouse hippocampal in situ epilepsy model. Male C57 mice (4-6 weeks) weighing between 20-25 grams were anesthetized with 5% isoflurane / oxygen mixed gas, fixed on a brain stereotaxic instrument, and maintained anesthesia by continuous inhalation of 1-2% isoflurane during the operation. Kainic acid (KA, 0.4μg, 0.5μL) was injected into the mouse hippocampus within 5 minutes. The location parameters of the injection area were: 2mm behind the anterior fontanelle, 2mm to the right of the midline, and 1.8mm deep in the frontal lobe. After the injection, the gas anesthesia was removed and the grade of epileptic seizures in the mice was observed. The evaluation criteria were as follows: grade 1, facial twitching, obvious chewing; grade 2, chewing, nodding and wet dog-like shaking; grade 3, unilateral forelimb clonus; grade 4, bilateral forelimb clonus; grade 5, rigidity, loss of balance and falling. The mice were divided into 1-5 seizure grades by observation and included in subsequent experiments. Based on the above operation, we replaced kainate with an equal volume of normal saline and injected it into the hippocampus of mice, which were normal saline control mice.

[0160] The HCB probe (120 nmol / kg) was injected into the tail vein. After 4 hours, the mice were anesthetized with 2% isoflurane and fixed on the operating table. After disinfection and draping, the scalp was cut, the muscles were separated, and a bone window (about 0.5×1 cm) was formed by electric drill to expose the surface of the cerebral cortex and retain the dura mater. We used a handheld Raman instrument (Ocean Optics QE65 Pro, excitation wavelength 785 nm, time 500 ms) for imaging. The handheld Raman instrument was connected to a computer and the Raman spectrum was displayed in real time through Oceanview software. First, we located the epileptic lesion by H2O2 imaging and found that the SERS intensity in the ipsilateral cortex was higher than that in the I 928 / I 482 In contrast, in normal brain, I 928 / I 482 The ratio remained relatively unchanged, and the surface HCB probe could specifically locate the epileptic focus. Subsequently, epileptic seizures of varying degrees were induced by intraperitoneal injection of KA, and synchronized neuronal activity led to a significant increase in the spike discharge of the local field potential. We observed through HCB probe imaging that the pH value in the epileptic focus decreased during the tonic phase and then gradually recovered after the epileptic seizure stopped. In addition, we observed that as the intensity of the epileptic seizure increased from level 2 to level 5, the acidity in the epileptic focus gradually increased. According to the calibration curve, the pH value during an epileptic seizure in mice can reach 6.6 ( Figure 2 ).

[0161] Example 8: Application of probe HCB to monitor drug efficacy during different treatments in mice

[0162] Mice with spontaneous epileptic seizures were selected and randomly divided into three groups, plus a sham operation group, and EEG was recorded for one week. Then, the HCB probe (120nmol / kg) was injected into the tail vein. After 4 hours, the mice were anesthetized and the skin on their heads was cut open. The mice were fixed on the lateral ventricle locator, and a cranial drill was used to drill a hole just above the cerebellum of the mice. We used a handheld Raman instrument (Ocean Optics QE65 Pro, excitation wavelength 785nm, time 500ms) to image, and collected Raman spectra of 64 sites of the mouse cerebral cortex through Oceanview software to obtain Raman maps, as shown in the figure. Figure 3 Before drug treatment, a higher I 928 / I 482 and I 928 / I 590 ratio, and the EEG data are consistent, such as Figure 3 shown.

[0163] Furthermore, the three groups of epilepsy model mice were intraperitoneally injected with DMSO, TPM and RTPM, respectively. During the drug treatment, we investigated the probe HCB to monitor the level of neuroinflammation and pH fluctuation in the brain. After the drug treatment, the probe HCB was again investigated to monitor the level of neuroinflammation and pH fluctuation in the brain. The operation process is as described above, and the results are as follows Figure 3 As shown in the figure, we found that the probe HCB can monitor the level of neuroinflammation and pH fluctuation in the brain in real time. The probe monitoring results showed that the brain I 928 / I 482 and I 928 / I 590 The ratio map signal was significantly higher than that of the sham operation group, indicating a high level of neuroinflammation and a lower pH in the brain. 928 / I 482 The ratio map signal was basically the same as that of the DMSO group, while I 928 / I 590 The ratio map signal increased, indicating that TPM could control the pH decrease caused by epileptic seizures. However, when the drug was stopped, 928 / I 590 The ratio map signal increased again to nearly the level before treatment, indicating that pH still showed a low level in the epileptic state and TPM had little effect on neuroinflammation. 928 / I 482 and I 928 / I 590 The ratio map signal was not significantly different from that of the DMSO group, which verified that RTPM could significantly restore neuroinflammation in mice and adjust pH to normal levels, and the therapeutic effect would not be invalidated by stopping the medication. This result is consistent with the EEG results.

Claims

1. A tandem ratio-response Raman probe, characterized in that: It is a substance composed of gold nano-substrate, dye molecules and polymers, and its structure is shown in the following formula V: Wherein, A is the gold nanosubstrate; X 1 The structure is as shown in Formula I a As shown: Among them, S is connected to the gold on the surface of A through a gold-sulfur bond, and R 1 and R 2 R is independently hydrogen, halogen, C1-C4 alkyl, sulfonic acid or nitro; 1 and R 2 Same or different; X 2 For L 1 -L 2 , L 1 is a group connected to the gold on the surface of A through a gold-sulfur bond, L 2 It is a hydrophilic polymer group, and the middle - indicates that the two are connected, the same below; X 3 For L 1 -L 3 -L 4 , L 1 is a group connected to the gold on the surface of A through a gold-sulfur bond, L 3 is a hydrophilic polymer group, L 4 is the targeting group; A is used as a substrate for Raman signal enhancement to provide electromagnetic field hotspots to enhance the Raman reporter molecule X 1 Raman signal, improving the sensitivity of detection; X 1 It is a reaction molecule with dual ratio responsiveness to H2O2 and pH, used to provide a quantitative basis for the target marker; X 2 Used to increase the biocompatibility of the probe; X 3 Endowing the probe with the ability to efficiently cross the blood-brain barrier.

2. The tandem ratio-response Raman probe according to claim 1, characterized in that: The particle size of A is 5nm to 200nm.

3. The tandem ratio-response Raman probe according to claim 1, characterized in that: In the substance represented by formula V: X 1 The molar ratio of A is 1×10 4 :1~5×10 4 :1;X 2 The molar ratio of A is 5×10 4 :1~50×10 4 :1;X 3 The molar ratio of A is 1×10 6 :1~3×10 6 :

1.

4. The tandem ratio-response Raman probe according to claim 1, characterized in that: The X2 structure is: The X 3 The structural formula is:

5. The tandem ratio-response Raman probe according to claim 1, characterized in that: The hydrated particle size of the substance represented by Formula V is 110±30 nm; The surface charge of the substance represented by Formula V is 9±5 mV; The substance represented by formula V has Raman effect.

6. The tandem ratio-response Raman probe according to claim 1, characterized in that: The Raman spectrum formed by the substance represented by Formula V has one or more of the following characteristic peaks: 303 cm -1 、482cm -1 、520cm -1 、552cm -1 、590cm -1 、928cm -1 、790cm -1 、1169cm -1 and 1430cm -1 The characteristic peak at .

7. Use of the tandem ratiometric response Raman probe according to any one of claims 1 to 6 in detecting reactive oxygen species and pH, wherein the reactive oxygen species is superoxide anion, hydrogen peroxide, singlet oxygen, hydroxyl radical, lipid peroxide radical, ozone, hypochlorite or hypobromite; The concentration of the active oxygen is 5 μmol / L to 100 μmol / L; The pH range for detecting active oxygen environment is 2.0 to 10.

0.

8. The use according to claim 7, characterized in that: The method comprises detecting organs, tissues or cells containing active oxygen and pH changes, wherein the organs, tissues or cells containing active oxygen and pH changes are neuronal cells or brain tissues.

9. The method for preparing a tandem ratio-response Raman probe according to any one of claims 1 to 6, characterized in that: In a solvent, the gold nano-substrate A, I a The substance X shown 1 、Polymer X 2 and polymer X 3 Reaction to obtain substance V; The solvent is an alcohol solvent and / or a water solvent.

10. The preparation method according to claim 9, characterized in that: The alcohol solvent is methanol and / or ethanol; the water solvent is deionized water, distilled water or purified water; When the solvent is a combination of an alcohol solvent and an aqueous solvent, the volume ratio of the alcohol solvent to the aqueous solvent is 1:10 to 1:500; The substance I a The molar ratio of A is 1×10 4 :1~5×10 4 :1; The polymer X 2 The molar ratio of A is 1×10 3 :1~1×10 5 :1; The polymer X 3 The molar ratio of A is 1×10 6 :1~5×10 6 :1; The polymer X 2 With polymer X 3 The molar ratio is 1:50 to 1:1000; The molar volume ratio of A to the solvent is 1:50 to 1:500; The substance I a The molar volume ratio with the solvent is 50:1 to 150:1; The polymer X 3 The molar volume ratio of the solvent is 5000:1 to 15000:1.

Citation Information

Patent Citations

  • Targeted Raman probe using core-shell gold nanoparticles as enhancing substrate

    CN110652598A

  • Biosensor chip, kit and method for detecting human 8-hydroxyguanine DNA glycosidase based on ratio-type SERS (Surface Enhanced Raman Scattering) method

    CN115369168A

  • Probe as well as preparation method and application thereof

    CN117462703A

  • Compounds and markers for surface-enhanced raman scattering

    US20100284917A1

  • Surface enhanced raman scattering nanoparticles and their use in detecting and imaging oxidative stress

    US20220233727A1

Cited By

  • Rapid detection robot and rapid detection method for environmental parameters of pharmaceutical workshop

    CN119643887A

  • Pathological blood-brain barrier targeting nano preparation for treating Alzheimer's disease and preparation method of pathological blood-brain barrier targeting nano preparation

    CN121606708A

  • A pathological blood-brain barrier targeting nano-preparation for treating Alzheimer's disease and a preparation method thereof

    CN121606708B